POTASSIUM CHLORIDE

Potassium Chloride Adverse Events Reported to the FDA Over Time

How are Potassium Chloride adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Potassium Chloride, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Potassium Chloride is flagged as the suspect drug causing the adverse event.

Most Common Potassium Chloride Adverse Events Reported to the FDA

What are the most common Potassium Chloride adverse events reported to the FDA?

Hyperkalaemia	179 (2.89%)
Completed Suicide	132 (2.13%)
Medication Error	89 (1.44%)
Cardiac Arrest	85 (1.37%)
Renal Failure Acute	79 (1.28%)
Drug Interaction	73 (1.18%)
Asthenia	68 (1.1%)
Diarrhoea	68 (1.1%)
Dyspnoea	67 (1.08%)
Dehydration	66 (1.07%)
Blood Potassium Increased	63 (1.02%)
	Show More
Nausea	59 (.95%)
Death	57 (.92%)
Toxic Epidermal Necrolysis	47 (.76%)
Renal Failure	46 (.74%)
Dizziness	45 (.73%)
Hypotension	43 (.7%)
Vomiting	43 (.7%)
Respiratory Arrest	42 (.68%)
Blood Creatinine Increased	40 (.65%)
Bradycardia	39 (.63%)
Cardio-respiratory Arrest	39 (.63%)
Overdose	39 (.63%)
Fatigue	35 (.57%)
Blood Potassium Decreased	34 (.55%)
Confusional State	33 (.53%)
Hypokalaemia	33 (.53%)
Malaise	33 (.53%)
Constipation	31 (.5%)
Drug Ineffective	31 (.5%)
Chronic Obstructive Pulmonary Disea...	30 (.49%)
Drug Exposure During Pregnancy	30 (.49%)
Headache	30 (.49%)
Oedema Peripheral	30 (.49%)
Pyrexia	30 (.49%)
Thrombocytopenia	30 (.49%)
Weight Decreased	29 (.47%)
Stevens-johnson Syndrome	28 (.45%)
Amnesia	27 (.44%)
Cardiac Failure	27 (.44%)
Coma	27 (.44%)
Haemoglobin Decreased	27 (.44%)
Bedridden	26 (.42%)
Erythema	26 (.42%)
Fall	26 (.42%)
Sinoatrial Block	26 (.42%)
Abdominal Pain	25 (.4%)
Emphysema	25 (.4%)
Arrhythmia	24 (.39%)
Somnolence	24 (.39%)
Weight Increased	24 (.39%)
Pruritus	23 (.37%)
Blood Pressure Increased	22 (.36%)
Blood Urea Increased	22 (.36%)
Condition Aggravated	22 (.36%)
Convulsion	22 (.36%)
Sinus Bradycardia	22 (.36%)
Urinary Tract Infection	22 (.36%)
Depression	21 (.34%)
Heart Rate Increased	21 (.34%)
Insomnia	21 (.34%)
Atrioventricular Block Second Degre...	20 (.32%)
Decreased Appetite	20 (.32%)
Hyperhidrosis	20 (.32%)
Visual Impairment	20 (.32%)
Agitation	19 (.31%)
Blood Glucose Increased	19 (.31%)
Chest Pain	19 (.31%)
Cytolytic Hepatitis	19 (.31%)
Pulmonary Arterial Hypertension	19 (.31%)
Sinus Tachycardia	19 (.31%)
Cough	18 (.29%)
Delirium	18 (.29%)
Drug Toxicity	18 (.29%)
Mitral Valve Incompetence	18 (.29%)
Alanine Aminotransferase Increased	17 (.27%)
Aspartate Aminotransferase Increase...	17 (.27%)
Hallucination, Visual	17 (.27%)
Hypertension	17 (.27%)
Oedema	17 (.27%)
Pancreatitis Acute	17 (.27%)
Sepsis	17 (.27%)
Abdominal Discomfort	16 (.26%)
Anaemia	16 (.26%)
Gait Disturbance	16 (.26%)
Haemodialysis	16 (.26%)
Muscle Spasms	16 (.26%)
Nodal Arrhythmia	16 (.26%)
Wrong Drug Administered	16 (.26%)
Chills	15 (.24%)
Gastrointestinal Haemorrhage	15 (.24%)
Loss Of Consciousness	15 (.24%)
Mental Impairment	15 (.24%)
Pain	15 (.24%)
Tachycardia	15 (.24%)
Abdominal Pain Upper	14 (.23%)
Atrial Fibrillation	14 (.23%)
Bradyarrhythmia	14 (.23%)
Circumstance Or Information Capable...	14 (.23%)
Drug Administration Error	14 (.23%)
Metabolic Acidosis	14 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Potassium Chloride, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Potassium Chloride is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Potassium Chloride

What are the most common Potassium Chloride adverse events reported to the FDA?

Cardiac Arrhythmias	418 (6.76%)
Electrolyte And Fluid Balance Condi...	328 (5.3%)
Medication Errors	271 (4.38%)
Epidermal And Dermal Conditions	233 (3.77%)
Neurological	232 (3.75%)
Respiratory	232 (3.75%)
Gastrointestinal Signs	204 (3.3%)
Renal Disorders	164 (2.65%)
Water, Electrolyte And Mineral	151 (2.44%)
Suicidal And Self-injurious Behavio...	146 (2.36%)
Cardiac And Vascular Investigations	140 (2.26%)
	Show More
Therapeutic And Nontherapeutic Effe...	125 (2.02%)
Hepatic And Hepatobiliary	115 (1.86%)
Infections - Pathogen Unspecified	114 (1.84%)
Gastrointestinal Motility And Defec...	107 (1.73%)
Hematology Investigations	100 (1.62%)
Chemical Injury And Poisoning	88 (1.42%)
Renal And Urinary Tract Investigati...	82 (1.33%)
Physical Examination Topics	74 (1.2%)
Decreased And Nonspecific Blood Pre...	67 (1.08%)
Urinary Tract Signs	64 (1.03%)
Deliria	63 (1.02%)
Fatal Outcomes	60 (.97%)
Mental Impairment	60 (.97%)
Metabolic, Nutritional And Blood Ga...	60 (.97%)
Cardiac Valve	56 (.91%)
Injuries	55 (.89%)
Hepatobiliary	49 (.79%)
Muscle	49 (.79%)
Lower Respiratory Tract Disorders	48 (.78%)
Lifestyle Issues	46 (.74%)
Gastrointestinal Hemorrhages	45 (.73%)
Heart Failures	43 (.7%)
Anxiety Disorders	42 (.68%)
Acid-base	41 (.66%)
Appetite And General Nutritional	41 (.66%)
Bronchial Disorders	41 (.66%)
Anemias Nonhemolytic And Marrow Dep...	38 (.61%)
Body Temperature Conditions	33 (.53%)
Seizures	33 (.53%)
Vision	33 (.53%)
Headaches	32 (.52%)
Platelet	32 (.52%)
Pulmonary Vascular	32 (.52%)
Movement Disorders	31 (.5%)
Product Quality Issues	29 (.47%)
Cardiac Disorder Signs	28 (.45%)
Procedural And Device Related Injur...	28 (.45%)
Administration Site Reactions	27 (.44%)
Allergic Conditions	26 (.42%)
Psychiatric	26 (.42%)
Ocular Infections, Irritations And ...	25 (.4%)
White Blood Cell	25 (.4%)
Central Nervous System Vascular	24 (.39%)
Coronary Artery	24 (.39%)
Exocrine Pancreas Conditions	24 (.39%)
Skin Appendage Conditions	24 (.39%)
Sleep Disorders	24 (.39%)
Depressed Mood Disorders	23 (.37%)
Hematological And Lymphoid Tissue T...	23 (.37%)
Upper Respiratory Tract Disorders	23 (.37%)
Enzyme	22 (.36%)
Musculoskeletal And Connective Tiss...	22 (.36%)
Oral Soft Tissue Conditions	22 (.36%)
Glucose Metabolism Disorders	21 (.34%)
Myocardial	21 (.34%)
Protein And Chemistry Analyses	21 (.34%)
Disturbances In Thinking	20 (.32%)
Vascular Hypertensive	20 (.32%)
Bacterial Infectious	19 (.31%)
Toxicology And Therapeutic Drug Mon...	19 (.31%)
Vascular	18 (.29%)
Gastrointestinal Ulceration And Per...	17 (.27%)
Bone, Calcium, Magnesium And Phosph...	16 (.26%)
Gastrointestinal Conditions	16 (.26%)
Maternal Complications Of Labour An...	15 (.24%)
Neonatal And Perinatal Conditions	15 (.24%)
Mood Disorders	14 (.23%)
Personality Disorders	14 (.23%)
Fungal Infectious	13 (.21%)
Obstetric And Gynecological Therape...	13 (.21%)
Therapeutic Procedures And Supporti...	13 (.21%)
Thyroid Gland	13 (.21%)
Angiedema And Urticaria	12 (.19%)
Joint	12 (.19%)
Neuromuscular	12 (.19%)
Arteriosclerosis, Stenosis, Vascula...	11 (.18%)
Eye	11 (.18%)
Inner Ear And Viiith Cranial Nerve	11 (.18%)
Spleen, Lymphatic And Reticulendoth...	11 (.18%)
Vascular Hemorrhagic	11 (.18%)
Endocrine Disorders Congenital	10 (.16%)
Gastrointestinal Stenosis And Obstr...	10 (.16%)
Ocular Neuromuscular	10 (.16%)
Abdominal Hernias And Other Abdomin...	9 (.15%)
Embolism And Thrombosis	9 (.15%)
Encephalopathies	9 (.15%)
Gastrointestinal Inflammatory Condi...	9 (.15%)
Dementia And Amnestic Conditions	8 (.13%)
Skin Vascular Abnormalities	8 (.13%)
Tongue Conditions	8 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Potassium Chloride, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Potassium Chloride is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.